FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 63 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,374,000 | -4.5% | 27,416 | 0.0% | 0.34% | -5.0% |
| Q3 2016 | $1,439,000 | +26.3% | 27,416 | -0.5% | 0.36% | +15.4% |
| Q2 2016 | $1,139,000 | +16.7% | 27,541 | +14.6% | 0.31% | +19.5% |
| Q1 2016 | $976,000 | -2.1% | 24,025 | 0.0% | 0.26% | -1.9% |
| Q4 2015 | $997,000 | +99.0% | 24,025 | -26.1% | 0.27% | +148.6% |
| Q3 2015 | $501,000 | +50000.0% | 32,525 | +130000.0% | 0.11% | – |
| Q2 2015 | $1,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 25 | -69.9% | 0.00% | – |
| Q2 2014 | $1,000 | – | 83 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
| AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
| BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
| Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
| Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
| Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
| RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
| Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |